The mGlu2 receptor plays a critical role in the effectiveness of ketamine for treating depression.
Ketamine may improve brain functions involved in mood regulation, researchers report.
A metabolite created as the body breaks down ketamine could hold the key to understanding its antidepressant action, a new study reports.
